Back to Agenda
Regulatory and Industry Perspectives: Understanding the Significance and Impact of GCP Inspection Observations
Session Chair(s)
Jenn Sellers, MD
Chief, GCP Assessment Branch
FDA, United States
Explore global GCP inspection outcomes featuring FDA’s 7-year data and international trends, highlighting compliance patterns, regulatory harmonization, and industry strategies for sustaining quality in complex global trials
Learning Objective : Compare and contrast GCP inspection classification and outcomes across regulatory agencies, highlighting similarities and differences in enforcement; Identify common deficiency patterns and regulatory expectations across regions, emphasizing protocol adherence, recordkeeping, and data integrity; Recognize the impact of inspection observations on regulatory decisions; Assess industry best practices.
Have an account?